The goal of this study is to test if a Digital PrEP Toolkit helps cisgender women learn about and access PrEP in Alabama and Mississippi. PrEP is a medication that prevents HIV infection. The main questions it aims to answer are: Can participants complete the Digital PrEP Toolkit in under 10 minutes? Do participants find the Digital PrEP Toolkit useful and easy to use? Does the Digital PrEP Toolkit increase the number of women who start taking PrEP? Investigators will work with up to 125 women at 3 HIV and STI clinics in Alabama and Mississippi. Participants will use the Digital PrEP Toolkit on a tablet at the clinic. They will answer questions about their HIV knowledge before and after using the Toolkit. Participants will then discuss PrEP options with a healthcare staff member and decide if they want to start PrEP. Participants will answer follow-up questions at 3 months. Investigators will also review participants' medical records at 6 months to see if they started PrEP and are still taking it.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Feasibility: Toolkit completion rate
Timeframe: Throughout 12-month enrollment period
Feasibility: Toolkit Completion Time
Timeframe: Throughout 12-month enrollment period
Acceptability: Participant Satisfaction
Timeframe: From enrollment to the end of the 3 month follow-up period at 15-months
Preliminary Efficacy: Participant PrEP Uptake
Timeframe: From enrollment to the end of the 3 month follow up period at 15-months
Preliminary Efficacy: Clinic-level PrEP uptake
Timeframe: From enrollment to the end of the 3 month follow up period at 15-months
Preliminary Efficacy: HIV and PrEP Knowledge
Timeframe: From enrollment to the end of the 3 month follow up period at 15-months